Acute fibrinous and organizing pneumonia after bone marrow transplantation, an underrecognized, severe condition

Anita Cassoli Cortez1, Maria Cristina Nunez Seiwald1, Ana Rita Brito Medeiros da Fonseca1

  • 1Bone Marrow Transplantation Department, Sírio Libanês Hospital, São Paulo, Brazil.

Abstract

Insights

Acute fibrinous organizing pneumonia is a rare, severe complication after allogeneic bone marrow transplantation. Early diagnosis and corticosteroid treatment improve outcomes, especially when initiated before Day +100.

Area of Science:

  • Pulmonary Medicine
  • Hematology
  • Transplantation Immunology

Background:

  • Allogeneic bone marrow transplantation (BMT) can cause pulmonary complications.
  • Acute fibrinous organizing pneumonia (AFOP) is a rare but severe complication post-BMT.
  • AFOP presents aggressively, differing from cryptogenic organizing pneumonia.

Purpose of the Study:

  • To review the literature on AFOP following BMT.
  • To analyze clinical features, treatments, and outcomes of AFOP post-BMT.
  • To present a case of AFOP post-BMT.

Main Methods:

  • Literature search of PubMed, Embase, Lilacs, and Cochrane databases.
  • Analysis of clinical data, therapeutic interventions, and patient outcomes.
  • Case report of a patient with AFOP post-BMT for acute myeloid leukemia.

Main Results:

  • The reviewed literature highlights AFOP as a severe post-BMT complication.
  • A case presented with severe hypoxemic respiratory failure, unresponsive to standard treatments.
  • Parainfluenza virus was identified, complicating the clinical picture.

Conclusions:

  • Early diagnosis and prompt corticosteroid therapy are crucial for better outcomes in AFOP post-BMT.
  • Treatment before Day +100 is associated with improved patient response and prognosis.
  • Developing more effective, targeted treatments for AFOP remains a significant challenge.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
713
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
885
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
772
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
858
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.5K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
742